MARKET

FMS

FMS

Fresenius Care
NYSE

Real-time Quotes | Nasdaq Last Sale

34.73
-0.61
-1.73%
After Hours: 34.60 -0.13 -0.37% 17:45 03/03 EST
OPEN
35.11
PREV CLOSE
35.34
HIGH
35.12
LOW
34.59
VOLUME
261.55K
TURNOVER
--
52 WEEK HIGH
46.55
52 WEEK LOW
29.17
MARKET CAP
20.34B
P/E (TTM)
14.37
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Fresenius Medical (FMS) Q4 Earnings Beat, Revenues Miss
Zacks.com · 02/24 19:50
Fresenius Medical (FMS) Q4 Earnings Beat, Revenues Miss
Zacks.com · 02/24 11:12
--Analyst Actions: RBC Adjusts Price Target on Fresenius Medical Care to $36 From $43, Maintains Sector Perform Rating
MT Newswires · 02/24 07:46
Research Alert: CFRA Keeps Buy Opinion On Adss Of Fresenius Medical Care
MT Newswires · 02/24 05:17
Fresenius Medical Care reports Q4 results
Fresenius Medical Care (FMS): Q4 Non-GAAP EPS of €1.27; GAAP EPS of €0.61.Revenue of €4.4B (-3.9% Y/Y)Press Release
Seekingalpha · 02/23 15:13
Recap: Fresenius Medical Care Q4 Earnings
Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to $0.76, which missed the estimate of $0.77. Revenue of $5,246,000,000 higher by 2.26% from the sa...
Benzinga · 02/23 14:28
Fresenius Medical Care Posts Lower Q4 Net Income
MT Newswires · 02/23 11:38
UPDATE 2-Fresenius reviews company structure after COVID-19 hit
reuters.com · 02/23 06:26
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FMS. Analyze the recent business situations of Fresenius Care through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FMS stock price target is 37.26 with a high estimate of 39.68 and a low estimate of 35.71.
EPS
Institutional Holdings
Institutions: 290
Institutional Holdings: 11.31M
% Owned: 1.93%
Shares Outstanding: 585.67M
TypeInstitutionsShares
Increased
50
426.15K
New
40
1.43M
Decreased
43
496.91K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-1.65%
Healthcare Providers & Services
-0.88%
Key Executives
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Corporate Executive
Harry De Wit
Vice President - Research & Development/Management Board
Olaf Schermeier
Management Board
Harry de Wit
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Management Board
Kent Wanzek
Independent Director/Supervisory Board
William Johnston
Supervisory Board
Deborah McWhinney
Independent Director/Supervisory Board
Dorothea Wenzel
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zund
Supervisory Board
Gregor Zuend
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
08/12/2020
Dividend USD 0.497802
08/28/2020
05/08/2019
Dividend USD 0.450194
05/17/2019
05/10/2018
Dividend USD 0.427
05/21/2018
05/17/2017
Dividend USD 0.37
05/11/2017
05/16/2016
Dividend USD 0.313
05/10/2016
05/21/2015
Dividend USD 0.298
05/15/2015
05/19/2014
Dividend USD 0.368
05/13/2014
05/20/2013
Dividend USD 0.334
05/14/2013
About FMS
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Webull offers kinds of Fresenius Medical Care AG & Co. KGaA stock information, including NYSE:FMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FMS stock methods without spending real money on the virtual paper trading platform.